Go Symbol Lookup
Loading...

Cramer Chats with Covidien’s CEO

 Text Size  
Published: Thursday, 26 Jul 2012 | 6:27 PM ET
By: CNBC.com

Although U.S. stocks closed sharply higher Thursday, “Mad Money” host Jim Cramer recommended investors remain defensive.

Covidien CEO on Earnings & Obamacare
Joe Almeida, Covidien plc chairman, president & CEO, discusses his company's medical device products and recent earnings, and the Supreme Court's health-care ruling.

Investors should look for well-run companies that are “aggressively trying to unlock value” and pay a juicy dividend, as well, Cramer said. He pointed to medical equipment maker Covidien, which reported strong earnings before Thursday’s opening bell. Cramer has long liked Covidien because he thinks it has a strong management team, which is trying to unlock value for shareholders by spinning off its pharmaceutical division while paying a dividend yield of around 1.8 percent.

To dig deeper into its earnings and learn more about its prospects, he welcomed CEO José Almeida onto the show. Check back soon to see the full interview.

@MadMoneyOnCNBC on Twitter

"Mad Money" on Facebook

Call Cramer: 1-800-743-CNBC

Questions for Cramer? madmoney@cnbc.com

Questions, comments, suggestions for the "Mad Money" website? madcap@cnbc.com

 Print
See his interview with José Almeida.

   
Comments

 

More Comments

 
 

Add Comments

 

Your Comments (Up to 1100 characters):

Remaining characters

Your comments have not been posted yet.

Please review your submission to make sure you are comfortable with your entry.

Your Comments:


                
            
            
        

Featured

Contact Mad Money

  • Showtimes

    Monday - Friday 6p | 11p ET
  • Cramer is host of CNBC's "Mad Money," and co-anchor of the 9 a.m. ET hour of CNBC's "Squawk on the Street."

Mad Money Features

  • Grab the latest CNBC gear from the NBCUniversal Store!

  • Get a behind-the-scenes look at how Cramer formulates his investment advice. "Inside the Madness" is a column, which features e-mails and more with Cramer and his researcher Nicole Urken.

  • You’ve always wanted to hit the “Hallelujah!” button. Here’s your chance.